![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Prostate Cancer |
Free Subscription
1 Acta Radiol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Comparative diagnostic performance of (68)Ga-PSMA-11 PET/CT and (68)Ga-PSMA-11
PET/MRI in detecting biochemical recurrent bone metastasis in prostate cancer: a
systematic review and meta-analysis.
Acta Radiol. 2025 Jan 26:2841851241307336. doi: 10.1177/02841851241307336.
PubMed
Abstract available
The 5-year results of the Stratified Cancer Active Surveillance programme for men
with prostate cancer.
BJU Int. 2025 Jan 29. doi: 10.1111/bju.16666.
PubMed
Abstract available
Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE
to improve treatment efficacy - protocol for the ERADICATE study: a phase II
randomised controlled trial.
BMC Cancer. 2025;25:160.
PubMed
Abstract available
External beam radiation therapy versus radical prostatectomy for high-risk
prostate cancer: protocol of the RECOVER study.
BMC Cancer. 2025;25:149.
PubMed
Abstract available
Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with
castration-resistant prostate cancer treated with docetaxel-based chemotherapy: a
meta-analysis.
BMC Urol. 2025;25:17.
PubMed
Abstract available
Consideration of initial steps to implementation of prostate cancer screening
following the EU recommendation.
BMJ Oncol. 2024;3:e000579.
PubMed
Defining national research priorities for prostate cancer in Zambia: using the
Delphi process for comprehensive cancer policy setting in sub-Saharan Africa.
BMJ Oncol. 2024;3:e000172.
PubMed
Abstract available
Comparison of standard-dose and reduced-dose treatment of metastatic prostate
cancer with enzalutamide, apalutamide or darolutamide: a rapid review.
BMJ Oncol. 2024;3:e000198.
PubMed
Abstract available
Tale of two zones: investigating the clinical outcomes and research gaps in
peripheral and transition zone prostate cancer through a systematic review and
meta-analysis.
BMJ Oncol. 2024;3:e000193.
PubMed
Abstract available
Targeting AXL inhibits the growth and metastasis of prostate cancer in bone.
Clin Cancer Res. 2025 Jan 29. doi: 10.1158/1078-0432.CCR-24-3028.
PubMed
Abstract available
Correction to: Metastatic Hormone-Sensitive Prostate Cancer in the Era of Doublet
and Triplet Therapy.
Curr Treat Options Oncol. 2025 Jan 25. doi: 10.1007/s11864-025-01294.
PubMed
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following
Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover
Trial.
Eur Urol. 2025;87:228-237.
PubMed
Abstract available
The Determinants of Toxicity in the Treatment of Prostate Cancer with a Focal,
Intraprostatic "Microboost".
Int J Radiat Oncol Biol Phys. 2025 Jan 22:S0360-3016(25)00054.
PubMed
Abstract available
Active surveillance for prostate cancer: How active is too active?
J Natl Cancer Inst. 2025 Jan 27:djae342. doi: 10.1093.
PubMed
An Artificial Intelligence Model Using Diffusion Basis Spectrum Imaging Metrics
Accurately Predicts Clinically Significant Prostate Cancer.
J Urol. 2025 Jan 27:101097JU0000000000004456. doi: 10.1097/JU.0000000000004456.
PubMed
Abstract available
Letter: Clinician-Reported Management Recommendations in Response to Universal
Germline Genetic Testing in Patients With Prostate Cancer.
J Urol. 2025 Jan 24:101097JU0000000000004420. doi: 10.1097/JU.0000000000004420.
PubMed
Epidemiology, diagnosis and treatment of anterior prostate cancer.
Nat Rev Urol. 2025 Jan 28. doi: 10.1038/s41585-024-00992.
PubMed
Abstract available
Constructing and Validating Models for Predicting Gleason Grade Group Upgrading
Following Radical Prostatectomy in Localized Prostate Cancer: A Comparison
between Machine Learning Algorithms and Conventional Logistic Regression.
Oncology. 2025 Jan 24:1-15. doi: 10.1159/000543492.
PubMed
Abstract available
xCT as a potential marker for neuroendocrine cells in high-risk prostate cancer
and the relation to AL122023.1-miR-26a/30d/30e axis.
PLoS One. 2025;20:e0318213.
PubMed
Abstract available
The impact of specialised gastroenterology services for pelvic radiation disease
(PRD): Results from the prospective multi-centre EAGLE study.
PLoS One. 2025;20:e0303356.
PubMed
Abstract available
Predicting the risk of bone metastases in patients with newly diagnosed prostate
cancer - Development and validation of a nomogram model.
PLoS One. 2025;20:e0318051.
PubMed
Abstract available
PI-RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic
Centers.
Prostate. 2025;85:337-343.
PubMed
Abstract available
PSA Density and Lesion Volume: Key Factors in Avoiding Unnecessary Biopsies for
PI-RADS 3 Lesions.
Prostate. 2025;85:385-390.
PubMed
Abstract available
Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of
Magnetic Resonance Imaging-Invisible Prostate Cancers: A Matched-Pair Analysis.
Prostate. 2025;85:374-384.
PubMed
Abstract available
Baseline Imaging Derived Factors of Response Following [225Ac]Ac-J591 Therapy in
Metastatic Castration-Resistant Prostate Cancer: A Lesion Level Analysis.
Prostate. 2025 Jan 23:e24853. doi: 10.1002/pros.24853.
PubMed
Abstract available
The Safety and Efficacy of Targeted Alpha Therapy, Ac-225 Prostate-Specific
Membrane Antigen, in Patients With Metastatic Castration-Resistant Prostate
Cancer: A Systematic Review and Meta-Analysis.
Prostate. 2025 Jan 26:e24857. doi: 10.1002/pros.24857.
PubMed
Abstract available
Comparing PSA Screening Patterns and Their Role as Predictor of Prostate Cancer
Diagnosis: Analysis of a Contemporary North American Cohort.
Prostate. 2025 Jan 27:e24856. doi: 10.1002/pros.24856.
PubMed
Abstract available
Optimizing Prostate Cancer Diagnostic Work-Up Through Micro-Ultrasound:
Minimizing Unnecessary Procedures and Reducing Overdiagnoses.
Prostate. 2025 Jan 28:e24862. doi: 10.1002/pros.24862.
PubMed
Abstract available
Reassessing the Role of Low PSA in Prognosis Across Grades of Prostate Cancer: A
Cohort Study.
Prostate. 2025 Jan 29:e24860. doi: 10.1002/pros.24860.
PubMed
Abstract available
Transcriptome-Wide Association Study Identified Novel Blood Tissue Gene
Biomarkers for Prostate Cancer Risk.
Prostate. 2025 Jan 29:e24859. doi: 10.1002/pros.24859.
PubMed
Abstract available
Immunohistochemical Analysis of Androgen Receptor Expression Predicts the
Prognosis of Metastatic Castration-Sensitive Prostate Cancer Patients Receiving
Abiraterone Acetate.
Prostate. 2025 Jan 31:e24865. doi: 10.1002/pros.24865.
PubMed
Abstract available
Thank you for your interest in scientific medicine.